Nevro controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2021
Jury finds Nevro infringed two Boston Scientific patents
Ruling
A Delaware jury found that Nevro infringed two Boston Scientific patents and awarded Boston Scientific $20 million. Nevro said it disagreed with the finding and planned to appeal.
Company response
Denial — Nevro
We disagree with the finding by the jury and plan to appeal
Source excerpt
We disagree with the finding by the jury and plan to appeal
today announced that a Delaware jury found that Nevro infringed two Boston Scientific patents (7,891,085 and 8,019,439) directed to ways of manufacturing spinal cord stimulation (SCS) leads, which Nevro obtains from a third-party supplier. Two other Boston Scientific lead patents (8,646,172 and 8,650,747) were not infringed. The jury awarded Boston Scientific $20 million.
2020
Nevro files patent lawsuit against Nalu Medical
Lawsuit filed
Nevro Corp. filed a patent-infringement lawsuit against Nalu Medical in the U.S. District Court for the District of Delaware, alleging that Nalu infringed Nevro patents covering the Senza system and HF10 therapy.
Source excerpt
today announced that it has filed a lawsuit for patent infringement against Nalu Medical, Inc.
The lawsuit, filed in the United States District Court for the District of Delaware on February 28, 2020, asserts that Nalu is infringing Nevro's patents covering inventions relating to Nevro's groundbreaking Senza® system and HF10® therapy.